Delivery Order SPE2DB20D1004-SPE2DB24FF8B1
Award Date 4/11/24
Potential Completion Date 4/12/24
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,542.09 delivery order contract is for the supply of Lialda DR 1.2 GM Tablets, a specialty medication. The contract has a completion date of September 7, 2021 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,049.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 120 tablets of the prescription medication LIALDA DR 1.2 GM with a completion date of February 2, 2024. This delivery order is part of Amerisourcebergen Drug Corp's larger $999,999,999.00 indefinite delivery contract with...
- The Defense Logistics Agency awarded a $2,537.85 delivery order to AmerisourceBergen Drug Corp for 120 tablets of LIALDA DR 1.2 GM on September 16, 2025, with completion expected by September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. LIALDA is a pharmaceutical treatment for inflammatory bowel disease, reflecting the agency's ongoing procurement of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on July 24, 2025, for LIALDA DR 1.2 GM Tablet 120s, a pharmaceutical product used in the treatment of inflammatory bowel disease. This competitively awarded, firm fixed-price contract carries a ceiling value of $8,154.24 and is scheduled for completion by July 25, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,752.94 Firm Fixed Price delivery order is for the drug Lialda, a tablet used to treat ulcerative colitis. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of 120 tablets of the pharmaceutical product LIALDA DR 1.2 GM. The contract has a ceiling value of $5,231.89 and a period of performance through November 24, 2023. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a significant single-award Indefinite Delivery Contract (IDC) valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count) with a ceiling value of $1,914.97. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The order is set to be completed by July 31, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count) on July 31, 2025, with a ceiling value of $1,422.22 and an ultimate completion date of August 1, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical procurement needs. The place of performance is located in...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 count tablets of the medication Mesalamine DR 1.2 GM, with a ceiling value of $1,173.30 and a period of performance ending on May 19, 2025. This delivery order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mesalamine DR 1.2 GM tablets in quantities of 60 units. This is a firm fixed-price delivery order with a ceiling value of $1,556.04, with an ultimate completion date of September 4, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate...